Stock market watch: What to expect from the week ending August 13, 2021
After this decisive breakout, technical analysts believe that Nifty will reach higher levels in coming weeks.
Global
Money Fleeing China Stocks May Overlook Pricey India, UBS Says – BloombergQuint
Money Fleeing China Stocks May Overlook Pricey India, UBS Says BloombergQuint
Up 2,146% in 1 year, Vulcan Energy (ASX:VUL) share price falls on dual listing news
Listing on multiple exchanges can increase a company’s profile and liquidity.The post Up 2,146% in 1 year, Vulcan Energy (ASX:VUL)…
Are you a ‘Catch and Release’ investor?
The ‘value’ of ‘growth’
The post Are you a ‘Catch and Release’ investor? appeared first on The Motley Fool Australia.
Stock Analysis
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne
HANGZHOU and SHAOXING, China, Aug. 8, 2021 /PRNewswire/ — Ascletis Pharma Inc. (HKEX code: 1672) today announces that China…
China NMPA Approves Phase II Clinical Trial of ASC40 for the Treatment of Patients with Acne
Ascletis Pharma Inc. (HKEX code: 1672) today announces that China National Medical Products Administration (NMPA) has approved…
Money Fleeing China Stocks May Overlook Pricey India, UBS Says
(Bloomberg) — Investors pulling out of China due to the recent regulatory crackdown may overlook India, where stocks are looking…
Why This Gold Stock Rallied 10% in July When Others Fell
Despite several analyst downgrades, interest in Franco-Nevada shares picked up ahead of its earnings release.
Epizyme and HUTCHMED Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazemetostat) in Greater China
CAMBRIDGE, Mass. & HONG KONG & SHANGHAI & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Epizyme, Inc. (“Epizyme”) (Nasdaq: EPZM), a fully…
If you invested $1,000 in Afterpay (ASX:APT) shares 4 years ago, here’s what it would be worth now
The company’s shares have been the talk of the town…The post If you invested $1,000 in Afterpay (ASX:APT) shares 4 years ago,…